HomeNews & MediaPress ReleasesSun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for Commercializing the specialty product FIBROMUNPress ReleasePublishedOctober 1, 2024Also available inItalianoSun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for Commercializing the specialty product FIBROMUNmore details
